| Emittent | Gattung | Typ | CUSIP/ISIN | Richtung | Bewertungsbasis | Handel | Bestand ($) | % NAV | Stück / Nennwert |
|---|---|---|---|---|---|---|---|---|---|
| Gesamt | 8.406.335 $ | 98,15 | 83.184 | ||||||
| Eli Lilly & Co | Eli Lilly & Co | EC | 532457108 | Long | Börsenkurs (Stufe 1) | 890.351 $ | 10,40 | 775 | |
| UnitedHealth Group Inc | UnitedHealth Group Inc | EC | 91324P102 | Long | Börsenkurs (Stufe 1) | 462.056 $ | 5,39 | 1.115 | |
| Johnson & Johnson | Johnson & Johnson | EC | 478160104 | Long | Börsenkurs (Stufe 1) | 424.516 $ | 4,96 | 1.656 | |
| Novartis AG | Novartis AG | EC | CH0012005267 | Long | Modellwert (Stufe 2) | 358.450 $ | 4,19 | 2.292 | |
| Natera Inc | Natera Inc | EC | 632307104 | Long | Börsenkurs (Stufe 1) | 308.192 $ | 3,60 | 1.151 | |
| Gilead Sciences Inc | Gilead Sciences Inc | EC | 375558103 | Long | Börsenkurs (Stufe 1) | 302.478 $ | 3,53 | 2.323 | |
| CVS Health Corp | CVS Health Corp | EC | 126650100 | Long | Börsenkurs (Stufe 1) | 285.512 $ | 3,33 | 2.734 | |
| Guardant Health Inc | Guardant Health Inc | EC | 40131M109 | Long | Börsenkurs (Stufe 1) | 223.708 $ | 2,61 | 1.381 | |
| Galderma Group AG | Galderma Group AG | EC | CH1335392721 | Long | Modellwert (Stufe 2) | 222.616 $ | 2,60 | 1.023 | |
| Thermo Fisher Scientific Inc | Thermo Fisher Scientific Inc | EC | 883556102 | Long | Börsenkurs (Stufe 1) | 198.134 $ | 2,31 | 345 | |
| Cogent Biosciences Inc | Cogent Biosciences Inc | EC | 19240Q201 | Long | Börsenkurs (Stufe 1) | 193.988 $ | 2,26 | 4.983 | |
| Vertex Pharmaceuticals Inc | Vertex Pharmaceuticals Inc | EC | 92532F100 | Long | Börsenkurs (Stufe 1) | 191.794 $ | 2,24 | 402 | |
| 10X Genomics Inc | 10X Genomics Inc | EC | 88025U109 | Long | Börsenkurs (Stufe 1) | 184.826 $ | 2,16 | 3.910 | |
| BeOne Medicines Ltd | BeOne Medicines Ltd | EC | CH1391448177 | Long | Modellwert (Stufe 2) | 176.278 $ | 2,06 | 7.131 | |
| Ascendis Pharma A/S | Ascendis Pharma A/S | EC | DK0060615755 | Long | Börsenkurs (Stufe 1) | 170.249 $ | 1,99 | 698 | |
| AstraZeneca PLC | AstraZeneca PLC | EC | GB0009895292 | Long | Modellwert (Stufe 2) | 168.749 $ | 1,97 | 992 | |
| Madrigal Pharmaceuticals Inc | Madrigal Pharmaceuticals Inc | EC | 558868105 | Long | Börsenkurs (Stufe 1) | 163.562 $ | 1,91 | 350 | |
| Bridgebio Pharma Inc | Bridgebio Pharma Inc | EC | 10806X102 | Long | Börsenkurs (Stufe 1) | 157.697 $ | 1,84 | 1.969 | |
| Edwards Lifesciences Corp | Edwards Lifesciences Corp | EC | 28176E108 | Long | Börsenkurs (Stufe 1) | 152.774 $ | 1,78 | 1.775 | |
| Revolution Medicines Inc | Revolution Medicines Inc | EC | 76155X100 | Long | Börsenkurs (Stufe 1) | 143.273 $ | 1,67 | 764 | |
| Arrowhead Pharmaceuticals Inc | Arrowhead Pharmaceuticals Inc | EC | 04280A100 | Long | Börsenkurs (Stufe 1) | 130.192 $ | 1,52 | 1.538 | |
| Protagonist Therapeutics Inc | Protagonist Therapeutics Inc | EC | 74366E102 | Long | Börsenkurs (Stufe 1) | 123.659 $ | 1,44 | 905 | |
| Dianthus Therapeutics Inc | Dianthus Therapeutics Inc | EC | 252828108 | Long | Börsenkurs (Stufe 1) | 123.172 $ | 1,44 | 1.152 | |
| Adaptive Biotechnologies Corp | Adaptive Biotechnologies Corp | EC | 00650F109 | Long | Börsenkurs (Stufe 1) | 122.036 $ | 1,42 | 5.407 | |
| Illumina Inc | Illumina Inc | EC | 452327109 | Long | Börsenkurs (Stufe 1) | 121.829 $ | 1,42 | 594 | |
| United Therapeutics Corp | United Therapeutics Corp | EC | 91307C102 | Long | Börsenkurs (Stufe 1) | 121.144 $ | 1,41 | 234 | |
| Argenx SE | Argenx SE | EC | NL0010832176 | Long | Modellwert (Stufe 2) | 121.641 $ | 1,42 | 142 | |
| UCB SA | UCB SA | EC | BE0003739530 | Long | Modellwert (Stufe 2) | 115.508 $ | 1,35 | 450 | |
| Mirum Pharmaceuticals Inc | Mirum Pharmaceuticals Inc | EC | 604749101 | Long | Börsenkurs (Stufe 1) | 115.168 $ | 1,34 | 1.087 | |
| Glaukos Corp | Glaukos Corp | EC | 377322102 | Long | Börsenkurs (Stufe 1) | 111.869 $ | 1,31 | 671 | |
| PTC Therapeutics Inc | PTC Therapeutics Inc | EC | 69366J200 | Long | Börsenkurs (Stufe 1) | 110.992 $ | 1,30 | 1.632 | |
| Teva Pharmaceutical Industries Ltd | Teva Pharmaceutical Industries Ltd | EC | 881624209 | Long | Börsenkurs (Stufe 1) | 103.525 $ | 1,21 | 2.957 | |
| Otsuka Holdings Co Ltd | Otsuka Holdings Co Ltd | EC | JP3188220002 | Long | Modellwert (Stufe 2) | 100.403 $ | 1,17 | 1.448 | |
| Intuitive Surgical Inc | Intuitive Surgical Inc | EC | 46120E602 | Long | Börsenkurs (Stufe 1) | 91.512 $ | 1,07 | 259 | |
| Roivant Sciences Ltd | Roivant Sciences Ltd | EC | BMG762791017 | Long | Börsenkurs (Stufe 1) | 90.675 $ | 1,06 | 2.674 | |
| CG oncology Inc | CG oncology Inc | EC | 156944100 | Long | Börsenkurs (Stufe 1) | 87.065 $ | 1,02 | 1.223 | |
| Hinge Health Inc | Hinge Health Inc | EC | 433313103 | Long | Börsenkurs (Stufe 1) | 83.899 $ | 0,98 | 1.123 | |
| Enliven Therapeutics Inc | Enliven Therapeutics Inc | EC | 29337E102 | Long | Börsenkurs (Stufe 1) | 81.009 $ | 0,95 | 1.478 | |
| Oruka Therapeutics Inc | Oruka Therapeutics Inc | EC | 687604108 | Long | Börsenkurs (Stufe 1) | 79.910 $ | 0,93 | 828 | |
| Celcuity Inc | Celcuity Inc | EC | 15102K100 | Long | Börsenkurs (Stufe 1) | 77.396 $ | 0,90 | 896 | |
| Encompass Health Corp | Encompass Health Corp | EC | 29261A100 | Long | Börsenkurs (Stufe 1) | 75.194 $ | 0,88 | 677 | |
| West Pharmaceutical Services Inc | West Pharmaceutical Services Inc | EC | 955306105 | Long | Börsenkurs (Stufe 1) | 69.556 $ | 0,81 | 204 | |
| Newamsterdam Pharma Co NV | Newamsterdam Pharma Co NV | EC | NL00150012L7 | Long | Börsenkurs (Stufe 1) | 69.364 $ | 0,81 | 2.496 | |
| Forte Biosciences Inc | Forte Biosciences Inc | EC | 34962G208 | Long | Börsenkurs (Stufe 1) | 67.485 $ | 0,79 | 881 | |
| Definium Therapeutics Inc | Definium Therapeutics Inc | EC | 24477V105 | Long | Börsenkurs (Stufe 1) | 63.496 $ | 0,74 | 1.459 | |
| Alumis Inc | Alumis Inc | EC | 022307102 | Long | Börsenkurs (Stufe 1) | 61.670 $ | 0,72 | 2.183 | |
| Stryker Corp | Stryker Corp | EC | 863667101 | Long | Börsenkurs (Stufe 1) | 60.580 $ | 0,71 | 186 | |
| Praxis Precision Medicines Inc | Praxis Precision Medicines Inc | EC | 74006W207 | Long | Börsenkurs (Stufe 1) | 59.411 $ | 0,69 | 193 | |
| Tango Therapeutics Inc | Tango Therapeutics Inc | EC | 87583X109 | Long | Börsenkurs (Stufe 1) | 54.360 $ | 0,63 | 2.000 | |
| Samsung Biologics Co Ltd | Samsung Biologics Co Ltd | EC | KR7207940008 | Long | Modellwert (Stufe 2) | beschränkt | 52.471 $ | 0,61 | 51 |
| IDEXX Laboratories Inc | IDEXX Laboratories Inc | EC | 45168D104 | Long | Börsenkurs (Stufe 1) | 49.757 $ | 0,58 | 89 | |
| HeartFlow Inc | HeartFlow Inc | EC | 42238D107 | Long | Börsenkurs (Stufe 1) | 40.418 $ | 0,47 | 1.602 | |
| DBV Technologies SA | DBV Technologies SA | EC | 23306J309 | Long | Börsenkurs (Stufe 1) | 40.136 $ | 0,47 | 2.973 | |
| Scholar Rock Holding Corp | Scholar Rock Holding Corp | EC | 80706P103 | Long | Börsenkurs (Stufe 1) | 38.876 $ | 0,45 | 822 | |
| Jade Biosciences Inc | Jade Biosciences Inc | EC | 008064206 | Long | Börsenkurs (Stufe 1) | 38.197 $ | 0,45 | 1.934 | |
| Kymera Therapeutics Inc | Kymera Therapeutics Inc | EC | 501575104 | Long | Börsenkurs (Stufe 1) | 37.431 $ | 0,44 | 362 | |
| BrightSpring Health Services Inc | BrightSpring Health Services Inc | EC | 10950A106 | Long | Börsenkurs (Stufe 1) | 36.125 $ | 0,42 | 605 | |
| Gesamt | 8.406.335 $ | 98,15 | 83.184 |